Create issue ticket

9,782 Possible Causes for IA, bone, morphogenetic, protein, receptor,, type

Did you mean: IA, bone, morphogenetic, proteus, receptor, type

  • Conductive Hearing Loss

    The access of bone morphogenetic protein (BMP) to the BMP receptors on the cell surface is regulated by its antagonist noggin, which binds to heparan-sulfate proteoglycans[ncbi.nlm.nih.gov] The pseudotumor expanded and destroyed the temporal bone and skin of the external ear over the course of 8 years.[ncbi.nlm.nih.gov] It's also possible to have both types – this is known as mixed hearing loss.[actiononhearingloss.org.uk] Craniometaphyseal dysplasia (CMD) is a rare, sclerosing skeletal disorder caused by mutations in ANKH, which encodes a putative pyrophosphate transporting membrane protein[ncbi.nlm.nih.gov] […] conductive hearing loss and a normal tympanic membrane (TM), and with soft tissue density in the middle ear cavity (MEC) on temporal bone computed tomography (TBCT) scan, open-type[ncbi.nlm.nih.gov] The air-bone gap was unchanged postoperatively.[ncbi.nlm.nih.gov]

  • Aristolochic Acid

    As some controversial studies have reported a nephroprotective effect of exogenous recombinant human bone morphogenetic protein (rhBMP)-7 in several models of renal fibrosis[ncbi.nlm.nih.gov] Understanding which human enzymes are involved in AAI activation to species forming DNA adducts and/or detoxication to the AAI O-demethylated metabolite, aristolochic acid Ia[ncbi.nlm.nih.gov] KEYWORDS: anemia; aristolochic acid; erythropoietin receptor; lysosome; molecular docking[ncbi.nlm.nih.gov] The correlation of cancer incidence with age, gender, dosage of aristolochic acid (AA), the type of renal replacement therapies, and the polymorphisms of quinone oxidoreductase[ncbi.nlm.nih.gov] This evidence shows, for the first time, that [Formula: see text]-actinin-4 is a protein targeted by AA-I in kidney cells.[ncbi.nlm.nih.gov] Our previous study showed that bone morphogenetic protein-7 (BMP-7) could attenuate AA-induced epithelial-to-mesenchymal transition (EMT) in human proximal tubule epithelial[ncbi.nlm.nih.gov]

  • Calcitonin

    METHODS: The expression of CT, transforming growth factor-beta 1(TGF-β1) and bone morphogenetic protein (BMP) in gingival crevicular fluid (GCF) was measured by ELISA.[ncbi.nlm.nih.gov] Temperature Frozen Specimen Stability Room temperature: Unacceptable Refrigerated: 24 hours Frozen: 28 days Reject Criteria Received room temperature Methodology Immunoassay (IA[questdiagnostics.com] OBJECTIVE: A case report of a giant cell reparative granuloma involving the temporal bone successfully treated with calcitonin. STUDY DESIGN: Case report.[ncbi.nlm.nih.gov] Abstract The calcitonin receptor-like receptor (CLR) is a class B G protein-coupled receptor (GPCR) that forms the basis of three pharmacologically distinct receptors, the[ncbi.nlm.nih.gov] Our results suggest that a type II turn is the preferred conformation of calcitonin, whereas a type I turn is the preferred conformation of peptides that require RAMPs; CGRP[ncbi.nlm.nih.gov] (CLR) and one of three receptor activity-modifying proteins (RAMPs).[ncbi.nlm.nih.gov]

  • Sodium Thiosulfate

    The mRNA and protein expressions of bone morphogenetic protein-2 (BMP-2), core binding factor α-1 (Cbfα-1), and matrix Gla protein (MGP) were detected.[ncbi.nlm.nih.gov] Cinacalcet, a calcimimetic agent that increases the sensitivity of the calcium-sensing receptor on the parathyroid gland to calcium, is believed to decrease serum parathyroid[ncbi.nlm.nih.gov] Cisplatin was neutralized by STS in CRT-IA but not in CRT-IV.[ncbi.nlm.nih.gov] The calcification findings were clearly shown on CT, and bone scintigraphy revealed diffuse uptake in the thoracic area.[ncbi.nlm.nih.gov] The reactions showed morphological features consistent with a contact allergic reaction, and the crescendo type of the response speaks in favour of an allergic nature.[ncbi.nlm.nih.gov] […] beneficial effects of STS were associated with attenuation of the lipopolysaccharide-induced nuclear factor-κB activation through the inhibition of tumor necrosis factor receptor-associated[ncbi.nlm.nih.gov]

  • Appendicitis

    Division of Pediatric Surgery, Greenville Health System, Greenville, SC. 15 Division of Pediatric Surgery, University of Iowa Stead Family Children's Hospital, Iowa City, IA[ncbi.nlm.nih.gov] KEYWORDS: Buffalo bone; Case report; Foreign body; Jejunum perforation; Local peritonitis[ncbi.nlm.nih.gov] BACKGROUND: Soluble urokinase plasminogen activator receptor (suPAR) is a new biomarker of inflammation level.[ncbi.nlm.nih.gov] To prevent unnecessary appendectomy, this type of infection should be made to ask in the history and clinical findings of patients.[ncbi.nlm.nih.gov] BACKGROUND: The C reactive protein (CRP) is one of the most accurate inflammatory markers in acute appendicitis (AA).[ncbi.nlm.nih.gov] TYPE OF STUDY: Retrospective Case-Control Study. LEVEL OF EVIDENCE: Level III. Published by Elsevier Inc.[ncbi.nlm.nih.gov]

    Missing: morphogenetic
  • Ovariectomy

    This study used the segmental long-bone defect model to assess the effects of osteoporosis on the formation of new bones and the osteoinductivity of recombinant human bone morphogenetic[ncbi.nlm.nih.gov] […] ovx to expand SCs; promote osteoblast proliferation and differentiation; regulate the SC production of the osteoclastogenic factors macrophage colony-stimulating factor, receptor[ncbi.nlm.nih.gov] proteins of fertilized eggs and reflecting the snail-intrinsic, reversible O-GalNAc glycosylations.[ncbi.nlm.nih.gov] Posto no burro, atura-Ias azoutas. Quen armou o treto que o desarme. Quen ben anda non cae. Quen fai as feitas ten que roer as sospeitas. Quen fai mal, agarde outro tal.[digalego.xunta.gal] […] with relative uncoupling of bone resorption from bone formation.[ncbi.nlm.nih.gov] BACKGROUND CONTEXT: Bone morphogenetic proteins (BMPs) enhance bone formation. Numerous animal studies have established that BMPs can augment spinal fusion.[ncbi.nlm.nih.gov]

  • Influenza Virus

    […] mail.xjtu.edu.cn. 2 School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, PR China. 3 Department of Microbiology, University of Iowa, Iowa City, IA[ncbi.nlm.nih.gov] Although early diagnosis followed by standard therapy with oseltamivir is thought to prevent influenza complications in myeloablative bone marrow transplant recipients, the[ncbi.nlm.nih.gov] Abstract The Formyl Peptide Receptor 2 (FPR2) is a novel promising target for the treatment of influenza.[ncbi.nlm.nih.gov] Influenza type C infections generally cause a mild respiratory illness and are not thought to cause epidemics.[cdc.gov] Here, we characterized the bat influenza A-like virus NS1 protein, a key virulence factor, and found unexpected functional divergence of this protein from counterparts in[ncbi.nlm.nih.gov] Sjaastad LE 1, 2 , Fay EJ 2, 3 , Fiege JK 1, 2 , Macchietto MG 4 , Stone IA 1, 2 , Markman MW 1, 2 , Shen S 4 , Langlois RA 5, 2, 3 .[ncbi.nlm.nih.gov]

    Missing: morphogenetic
  • Brachydactyly

    […] additional occurrence of proximal symphalangism and carpal synostosis, we identified six different point mutations (P35A, P35S, A36P, E48K, R167G, and P187S) in the bone morphogenetic[ncbi.nlm.nih.gov] Types Ia (PHP-Ia), Ib, Ic, and II are distinguished on the basis of their pathogenesis and phenotypes ( 4 , 5 ).[academic.oup.com] However, brachydactyly in association with absence of nasal bone is rare.[ncbi.nlm.nih.gov] Abstract The transmembrane receptor 'ROR2' resembles members of the receptor tyrosine kinase family of signalling receptors in sequence but its' signal transduction mechanisms[ncbi.nlm.nih.gov] Abstract Brachydactyly type C is an autosomal dominant disorder with markedly variable penetrance.[ncbi.nlm.nih.gov] We propose a model in which the RRS versus the BDB1 phenotype is determined by the relative degree of protein retention/degradation and the amount of mutant protein reaching[ncbi.nlm.nih.gov]

  • Triamcinolone

    […] apoptosis; inhibits prostaglandin synthesis; impairs tumor necrosis factor (TNF)-α-induced degradation of κB-α; potentiates the differentiation-inducing effects of bone morphogenetic[sigmaaldrich.com] OBJECTIVE: Intra-articular (IA) corticosteroids relieve osteoarthritis (OA) pain, but rapid absorption into systemic circulation may limit efficacy and produce untoward effects[ncbi.nlm.nih.gov] From the radiographic exam, we observed a radiolucent image in the mandibular bone with well-defined limits extending from the apical region of tooth 33 to the apical region[ncbi.nlm.nih.gov] These drugs bind to the glucocorticoid receptor (GR), a ligand-activated transcription factor and member of the nuclear receptor superfamily.[ncbi.nlm.nih.gov] […] detachment (47%)) and type 3 (complete posterior vitreous detachment (32%)).[ncbi.nlm.nih.gov] The aqueous concentrations of interleukin (IL)-6, IL-8, interferon-induced protein (IP)-10, monocyte chemotactic protein (MCP)-1, platelet-derived growth factor (PDGF)-AA,[ncbi.nlm.nih.gov]

  • Osteogenesis Imperfecta

    It encodes two isoforms, bone morphogenetic protein 1 (BMP1) and mammalian tolloid (mTLD); both have proteolytic activity to remove the C-propeptide from procollagen.[ncbi.nlm.nih.gov] It remains controversial whether IAs are caused by OI or IAs are coincidentally complicated with OI.[ncbi.nlm.nih.gov] Society for Bone and Mineral Research.[ncbi.nlm.nih.gov] The specific mu receptor agonist DAMGO activated potassium currents in oocytes expressing the mu receptor that were fully inhibited by the mu receptor antagonist, naloxone[medicalmarijuana.com] […] with OI type I, and 27 age- and sex-matched controls.[ncbi.nlm.nih.gov] KEYWORDS: Autophagy; Chemical chaperone; Collagen; Endoplasmic reticulum stress; Osteogenesis imperfecta; Unfolded protein response[ncbi.nlm.nih.gov]